Noul Co.,Ltd. (KOSDAQ:376930)
South Korea · Delayed Price · Currency is KRW 1,893.00
+7.00 (0.37%)
At close: Jan 23, 2026
Noul Co.,Ltd. Revenue
Noul Co.,Ltd. had revenue of 1.08B KRW in the quarter ending September 30, 2025, a decrease of -20.37%. This brings the company's revenue in the last twelve months to 3.91B, up 72.55% year-over-year. In the year 2024, Noul Co.,Ltd. had annual revenue of 1.60B, down -41.42%.
Revenue (ttm)
3.91B
Revenue Growth
+72.55%
P/S Ratio
24.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
97.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.60B | -1.13B | -41.42% |
| Dec 31, 2023 | 2.73B | 2.19B | 404.51% |
| Dec 31, 2022 | 541.88M | -933.43M | -63.27% |
| Dec 31, 2021 | 1.48B | 1.18B | 399.66% |
| Dec 31, 2020 | 295.26M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 120.30B |
| Genoray | 102.75B |
| DRGEM | 98.34B |
| JPI Healthcare | 52.79B |
| CU Medical Systems | 44.79B |
| Hironic | 33.18B |
| SELVAS Healthcare | 29.79B |
| Remed | 24.26B |